CardioExchange Archive

European Medicines Agency Also Reviewing Avandia: In addition to all the rosiglitazone news surrounding the FDA advisory panel on July 13-14, the European Medicines Agency announced on Friday that it has initiated its own review of the cardiovascular safety of the drug.



AHA Publishes Scientific Statement on Diet and Exercise Interventions: The AHA has published a detailed scientific statement to assist physicians in changing the behavior of their patients. The most effective intervention is a combination of counseling, extended follow-up with a healthcare professional, and self-monitoring of diet and exercise, according to the statement. The authors also call for modification of healthcare policy to better allow healthcare professionals to encourage these changes.

“As healthcare providers, we’re pretty good at saying that you are at risk for a disease, you need to lose weight, be more physically active, and eat more fruits and vegetables. While that’s easy to say, it’s not easy for the person to actually translate it into their everyday life,” said the chair of the writing committee, Nancy T. Artinian, in an AHA press release.